Project
Illumina Body Map 2: averaged replicates
Navigation
Downloads
Results for PPARG
Z-value: 2.46
Motif logo
Transcription factors associated with PPARG
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
PPARG
|
ENSG00000132170.15 | peroxisome proliferator activated receptor gamma |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| PPARG | hg19_v2_chr3_+_12329397_12329433 | 0.28 | 1.3e-01 | Click! |
Activity profile of PPARG motif
Sorted Z-values of PPARG motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr19_-_49864746 | 10.32 |
ENST00000598810.1
|
TEAD2
|
TEA domain family member 2 |
| chr22_+_23029188 | 5.58 |
ENST00000390305.2
|
IGLV3-25
|
immunoglobulin lambda variable 3-25 |
| chr22_+_23229960 | 5.41 |
ENST00000526893.1
ENST00000532223.2 ENST00000531372.1 |
IGLL5
|
immunoglobulin lambda-like polypeptide 5 |
| chr14_-_106330458 | 5.20 |
ENST00000461719.1
|
IGHJ4
|
immunoglobulin heavy joining 4 |
| chr22_+_22676808 | 4.37 |
ENST00000390290.2
|
IGLV1-51
|
immunoglobulin lambda variable 1-51 |
| chr2_-_89513402 | 4.32 |
ENST00000498435.1
|
IGKV1-27
|
immunoglobulin kappa variable 1-27 |
| chr8_+_11351494 | 4.24 |
ENST00000259089.4
|
BLK
|
B lymphoid tyrosine kinase |
| chr8_+_11351876 | 4.04 |
ENST00000529894.1
|
BLK
|
B lymphoid tyrosine kinase |
| chr14_-_106453155 | 4.03 |
ENST00000390594.2
|
IGHV1-2
|
immunoglobulin heavy variable 1-2 |
| chr14_-_106642049 | 3.92 |
ENST00000390605.2
|
IGHV1-18
|
immunoglobulin heavy variable 1-18 |
| chr22_+_23264766 | 3.91 |
ENST00000390331.2
|
IGLC7
|
immunoglobulin lambda constant 7 |
| chr10_-_72362515 | 3.89 |
ENST00000373209.2
ENST00000441259.1 |
PRF1
|
perforin 1 (pore forming protein) |
| chr14_-_106330824 | 3.84 |
ENST00000463911.1
|
IGHJ3
|
immunoglobulin heavy joining 3 |
| chr19_+_544034 | 3.78 |
ENST00000592501.1
ENST00000264553.3 |
GZMM
|
granzyme M (lymphocyte met-ase 1) |
| chr19_-_10445399 | 3.32 |
ENST00000592945.1
|
ICAM3
|
intercellular adhesion molecule 3 |
| chr7_+_80253387 | 3.30 |
ENST00000438020.1
|
CD36
|
CD36 molecule (thrombospondin receptor) |
| chr22_+_22681656 | 3.18 |
ENST00000390291.2
|
IGLV1-50
|
immunoglobulin lambda variable 1-50 (non-functional) |
| chr11_+_14665373 | 3.09 |
ENST00000455098.2
|
PDE3B
|
phosphodiesterase 3B, cGMP-inhibited |
| chr14_-_106471723 | 3.04 |
ENST00000390595.2
|
IGHV1-3
|
immunoglobulin heavy variable 1-3 |
| chr2_-_219031709 | 3.02 |
ENST00000295683.2
|
CXCR1
|
chemokine (C-X-C motif) receptor 1 |
| chr2_+_112895939 | 2.99 |
ENST00000331203.2
ENST00000409903.1 ENST00000409667.3 ENST00000409450.3 |
FBLN7
|
fibulin 7 |
| chr14_-_106866934 | 2.96 |
ENST00000390618.2
|
IGHV3-38
|
immunoglobulin heavy variable 3-38 (non-functional) |
| chr19_+_50016411 | 2.95 |
ENST00000426395.3
ENST00000600273.1 ENST00000599988.1 |
FCGRT
|
Fc fragment of IgG, receptor, transporter, alpha |
| chr12_-_53601000 | 2.81 |
ENST00000338737.4
ENST00000549086.2 |
ITGB7
|
integrin, beta 7 |
| chr19_+_18283959 | 2.73 |
ENST00000597802.2
|
IFI30
|
interferon, gamma-inducible protein 30 |
| chr9_-_130524695 | 2.73 |
ENST00000440630.1
ENST00000429553.1 |
SH2D3C
|
SH2 domain containing 3C |
| chr1_+_2487078 | 2.71 |
ENST00000426449.1
ENST00000434817.1 ENST00000435221.2 |
TNFRSF14
|
tumor necrosis factor receptor superfamily, member 14 |
| chr1_-_154941350 | 2.62 |
ENST00000444179.1
ENST00000414115.1 |
SHC1
|
SHC (Src homology 2 domain containing) transforming protein 1 |
| chr14_+_105046021 | 2.59 |
ENST00000557649.1
|
C14orf180
|
chromosome 14 open reading frame 180 |
| chr9_-_117150243 | 2.58 |
ENST00000374088.3
|
AKNA
|
AT-hook transcription factor |
| chr1_-_183538319 | 2.54 |
ENST00000420553.1
ENST00000419402.1 |
NCF2
|
neutrophil cytosolic factor 2 |
| chr17_-_18945798 | 2.47 |
ENST00000395635.1
|
GRAP
|
GRB2-related adaptor protein |
| chr20_+_43803517 | 2.45 |
ENST00000243924.3
|
PI3
|
peptidase inhibitor 3, skin-derived |
| chr22_+_23089870 | 2.43 |
ENST00000390311.2
|
IGLV3-16
|
immunoglobulin lambda variable 3-16 |
| chr1_+_2487402 | 2.38 |
ENST00000451778.1
|
TNFRSF14
|
tumor necrosis factor receptor superfamily, member 14 |
| chr12_+_57849048 | 2.34 |
ENST00000266646.2
|
INHBE
|
inhibin, beta E |
| chr14_+_22748980 | 2.26 |
ENST00000390465.2
|
TRAV38-2DV8
|
T cell receptor alpha variable 38-2/delta variable 8 |
| chr19_+_50016610 | 2.22 |
ENST00000596975.1
|
FCGRT
|
Fc fragment of IgG, receptor, transporter, alpha |
| chr16_+_29817399 | 2.20 |
ENST00000545521.1
|
MAZ
|
MYC-associated zinc finger protein (purine-binding transcription factor) |
| chr9_-_33447584 | 2.20 |
ENST00000297991.4
|
AQP3
|
aquaporin 3 (Gill blood group) |
| chr2_+_85922491 | 2.19 |
ENST00000526018.1
|
GNLY
|
granulysin |
| chr14_+_105046094 | 2.18 |
ENST00000331952.2
|
C14orf180
|
chromosome 14 open reading frame 180 |
| chr7_-_150498426 | 2.17 |
ENST00000447204.2
|
TMEM176B
|
transmembrane protein 176B |
| chr22_+_23241661 | 2.15 |
ENST00000390322.2
|
IGLJ2
|
immunoglobulin lambda joining 2 |
| chr7_+_150498610 | 2.15 |
ENST00000461345.1
|
TMEM176A
|
transmembrane protein 176A |
| chr9_-_139927462 | 2.15 |
ENST00000314412.6
|
FUT7
|
fucosyltransferase 7 (alpha (1,3) fucosyltransferase) |
| chrX_+_135252050 | 2.12 |
ENST00000449474.1
ENST00000345434.3 |
FHL1
|
four and a half LIM domains 1 |
| chr8_-_27850180 | 2.12 |
ENST00000380385.2
ENST00000301906.4 ENST00000354914.3 |
SCARA5
|
scavenger receptor class A, member 5 (putative) |
| chr17_+_42427826 | 2.12 |
ENST00000586443.1
|
GRN
|
granulin |
| chr14_+_105953246 | 2.11 |
ENST00000392531.3
|
CRIP1
|
cysteine-rich protein 1 (intestinal) |
| chr1_+_207070775 | 2.10 |
ENST00000391929.3
ENST00000294984.2 ENST00000367093.3 |
IL24
|
interleukin 24 |
| chr4_-_25865159 | 2.07 |
ENST00000502949.1
ENST00000264868.5 ENST00000513691.1 ENST00000514872.1 |
SEL1L3
|
sel-1 suppressor of lin-12-like 3 (C. elegans) |
| chr11_+_14665263 | 2.05 |
ENST00000282096.4
|
PDE3B
|
phosphodiesterase 3B, cGMP-inhibited |
| chr14_+_105953204 | 2.00 |
ENST00000409393.2
|
CRIP1
|
cysteine-rich protein 1 (intestinal) |
| chr14_+_21152259 | 2.00 |
ENST00000555835.1
ENST00000336811.6 |
RNASE4
ANG
|
ribonuclease, RNase A family, 4 angiogenin, ribonuclease, RNase A family, 5 |
| chr14_+_22670455 | 1.98 |
ENST00000390460.1
|
TRAV26-2
|
T cell receptor alpha variable 26-2 |
| chr8_-_27850141 | 1.97 |
ENST00000524352.1
|
SCARA5
|
scavenger receptor class A, member 5 (putative) |
| chr11_-_5255861 | 1.96 |
ENST00000380299.3
|
HBD
|
hemoglobin, delta |
| chr11_+_75479763 | 1.96 |
ENST00000228027.7
|
DGAT2
|
diacylglycerol O-acyltransferase 2 |
| chr17_+_45286706 | 1.95 |
ENST00000393450.1
ENST00000572303.1 |
MYL4
|
myosin, light chain 4, alkali; atrial, embryonic |
| chr19_+_49661037 | 1.95 |
ENST00000427978.2
|
TRPM4
|
transient receptor potential cation channel, subfamily M, member 4 |
| chr20_+_31870927 | 1.95 |
ENST00000253354.1
|
BPIFB1
|
BPI fold containing family B, member 1 |
| chr8_-_25902876 | 1.93 |
ENST00000520164.1
|
EBF2
|
early B-cell factor 2 |
| chr19_-_54784353 | 1.93 |
ENST00000391746.1
|
LILRB2
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2 |
| chr14_-_106331652 | 1.89 |
ENST00000390565.1
|
IGHJ1
|
immunoglobulin heavy joining 1 |
| chr9_-_117150303 | 1.89 |
ENST00000312033.3
|
AKNA
|
AT-hook transcription factor |
| chr19_+_850985 | 1.88 |
ENST00000590230.1
|
ELANE
|
elastase, neutrophil expressed |
| chr7_+_150498783 | 1.87 |
ENST00000475536.1
ENST00000468689.1 |
TMEM176A
|
transmembrane protein 176A |
| chr1_+_200011711 | 1.84 |
ENST00000544748.1
|
NR5A2
|
nuclear receptor subfamily 5, group A, member 2 |
| chr17_-_7297519 | 1.84 |
ENST00000576362.1
ENST00000571078.1 |
TMEM256-PLSCR3
|
TMEM256-PLSCR3 readthrough (NMD candidate) |
| chr7_-_75443118 | 1.83 |
ENST00000222902.2
|
CCL24
|
chemokine (C-C motif) ligand 24 |
| chr19_+_42388437 | 1.81 |
ENST00000378152.4
ENST00000337665.4 |
ARHGEF1
|
Rho guanine nucleotide exchange factor (GEF) 1 |
| chr5_-_180076613 | 1.80 |
ENST00000261937.6
ENST00000393347.3 |
FLT4
|
fms-related tyrosine kinase 4 |
| chr12_-_96390108 | 1.78 |
ENST00000538703.1
ENST00000261208.3 |
HAL
|
histidine ammonia-lyase |
| chr9_+_95709733 | 1.76 |
ENST00000375482.3
|
FGD3
|
FYVE, RhoGEF and PH domain containing 3 |
| chr6_-_112575838 | 1.74 |
ENST00000455073.1
|
LAMA4
|
laminin, alpha 4 |
| chr1_+_10057274 | 1.74 |
ENST00000294435.7
|
RBP7
|
retinol binding protein 7, cellular |
| chr22_-_24096630 | 1.73 |
ENST00000248948.3
|
VPREB3
|
pre-B lymphocyte 3 |
| chr17_-_7297833 | 1.71 |
ENST00000571802.1
ENST00000576201.1 ENST00000573213.1 ENST00000324822.11 |
TMEM256-PLSCR3
|
TMEM256-PLSCR3 readthrough (NMD candidate) |
| chr19_+_51645556 | 1.71 |
ENST00000601682.1
ENST00000317643.6 ENST00000305628.7 ENST00000600577.1 |
SIGLEC7
|
sialic acid binding Ig-like lectin 7 |
| chr2_-_87018784 | 1.70 |
ENST00000283635.3
ENST00000538832.1 |
CD8A
|
CD8a molecule |
| chr5_-_176936844 | 1.69 |
ENST00000510380.1
ENST00000510898.1 ENST00000357198.4 |
DOK3
|
docking protein 3 |
| chr5_-_176936817 | 1.66 |
ENST00000502885.1
ENST00000506493.1 |
DOK3
|
docking protein 3 |
| chr19_-_55836697 | 1.66 |
ENST00000438693.1
ENST00000591570.1 |
TMEM150B
|
transmembrane protein 150B |
| chr19_-_54746600 | 1.65 |
ENST00000245621.5
ENST00000270464.5 ENST00000419410.2 ENST00000391735.3 ENST00000396365.2 ENST00000440558.2 ENST00000407860.2 |
LILRA6
LILRB3
|
leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6 leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3 |
| chr11_-_5255696 | 1.65 |
ENST00000292901.3
ENST00000417377.1 |
HBD
|
hemoglobin, delta |
| chr7_+_75932863 | 1.61 |
ENST00000429938.1
|
HSPB1
|
heat shock 27kDa protein 1 |
| chr19_+_49661079 | 1.61 |
ENST00000355712.5
|
TRPM4
|
transient receptor potential cation channel, subfamily M, member 4 |
| chr5_-_180076580 | 1.60 |
ENST00000502649.1
|
FLT4
|
fms-related tyrosine kinase 4 |
| chr10_+_114135952 | 1.59 |
ENST00000356116.1
ENST00000433418.1 ENST00000354273.4 |
ACSL5
|
acyl-CoA synthetase long-chain family member 5 |
| chr5_-_180242576 | 1.59 |
ENST00000514438.1
|
MGAT1
|
mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase |
| chr14_+_23341513 | 1.59 |
ENST00000546834.1
|
LRP10
|
low density lipoprotein receptor-related protein 10 |
| chr10_-_129924468 | 1.57 |
ENST00000368653.3
|
MKI67
|
marker of proliferation Ki-67 |
| chr12_+_6494285 | 1.56 |
ENST00000541102.1
|
LTBR
|
lymphotoxin beta receptor (TNFR superfamily, member 3) |
| chr17_-_34207295 | 1.55 |
ENST00000463941.1
ENST00000293272.3 |
CCL5
|
chemokine (C-C motif) ligand 5 |
| chr4_+_15704573 | 1.55 |
ENST00000265016.4
|
BST1
|
bone marrow stromal cell antigen 1 |
| chr21_-_43771226 | 1.51 |
ENST00000291526.4
|
TFF2
|
trefoil factor 2 |
| chr4_+_15704679 | 1.51 |
ENST00000382346.3
|
BST1
|
bone marrow stromal cell antigen 1 |
| chr1_+_12185949 | 1.50 |
ENST00000413146.2
|
TNFRSF8
|
tumor necrosis factor receptor superfamily, member 8 |
| chr5_-_180242534 | 1.48 |
ENST00000333055.3
ENST00000513431.1 |
MGAT1
|
mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase |
| chr7_-_100425112 | 1.47 |
ENST00000358173.3
|
EPHB4
|
EPH receptor B4 |
| chr11_+_46740730 | 1.46 |
ENST00000311907.5
ENST00000530231.1 ENST00000442468.1 |
F2
|
coagulation factor II (thrombin) |
| chr22_+_37309662 | 1.45 |
ENST00000403662.3
ENST00000262825.5 |
CSF2RB
|
colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage) |
| chr3_+_148415571 | 1.45 |
ENST00000497524.1
ENST00000349243.3 ENST00000542281.1 ENST00000418473.2 ENST00000404754.2 |
AGTR1
|
angiotensin II receptor, type 1 |
| chr17_+_61571746 | 1.44 |
ENST00000579409.1
|
ACE
|
angiotensin I converting enzyme |
| chr6_-_52441713 | 1.44 |
ENST00000182527.3
|
TRAM2
|
translocation associated membrane protein 2 |
| chr11_+_308143 | 1.44 |
ENST00000399817.4
|
IFITM2
|
interferon induced transmembrane protein 2 |
| chr3_-_133748758 | 1.44 |
ENST00000493729.1
|
SLCO2A1
|
solute carrier organic anion transporter family, member 2A1 |
| chr19_+_49660997 | 1.43 |
ENST00000598691.1
ENST00000252826.5 |
TRPM4
|
transient receptor potential cation channel, subfamily M, member 4 |
| chr20_+_48884002 | 1.42 |
ENST00000425497.1
ENST00000445003.1 |
RP11-290F20.3
|
RP11-290F20.3 |
| chr12_-_96390063 | 1.42 |
ENST00000541929.1
|
HAL
|
histidine ammonia-lyase |
| chr19_-_13213954 | 1.42 |
ENST00000590974.1
|
LYL1
|
lymphoblastic leukemia derived sequence 1 |
| chr11_+_75526212 | 1.41 |
ENST00000356136.3
|
UVRAG
|
UV radiation resistance associated |
| chr1_+_158815588 | 1.41 |
ENST00000438394.1
|
MNDA
|
myeloid cell nuclear differentiation antigen |
| chr19_-_55836669 | 1.38 |
ENST00000326652.4
|
TMEM150B
|
transmembrane protein 150B |
| chr8_-_82024290 | 1.38 |
ENST00000220597.4
|
PAG1
|
phosphoprotein associated with glycosphingolipid microdomains 1 |
| chr11_+_67171548 | 1.37 |
ENST00000542590.1
|
TBC1D10C
|
TBC1 domain family, member 10C |
| chr11_+_67171358 | 1.36 |
ENST00000526387.1
|
TBC1D10C
|
TBC1 domain family, member 10C |
| chr5_-_150460539 | 1.36 |
ENST00000520931.1
ENST00000520695.1 ENST00000521591.1 ENST00000518977.1 |
TNIP1
|
TNFAIP3 interacting protein 1 |
| chr6_-_112575758 | 1.35 |
ENST00000431543.2
ENST00000453937.2 ENST00000368638.4 ENST00000389463.4 |
LAMA4
|
laminin, alpha 4 |
| chr10_+_102758105 | 1.34 |
ENST00000429732.1
|
LZTS2
|
leucine zipper, putative tumor suppressor 2 |
| chr2_-_32490801 | 1.34 |
ENST00000360906.5
ENST00000342905.6 |
NLRC4
|
NLR family, CARD domain containing 4 |
| chr3_+_52811596 | 1.34 |
ENST00000542827.1
ENST00000273283.2 |
ITIH1
|
inter-alpha-trypsin inhibitor heavy chain 1 |
| chr11_+_67171391 | 1.34 |
ENST00000312390.5
|
TBC1D10C
|
TBC1 domain family, member 10C |
| chr5_+_149865377 | 1.33 |
ENST00000522491.1
|
NDST1
|
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 1 |
| chr7_-_38370536 | 1.33 |
ENST00000390343.2
|
TRGV8
|
T cell receptor gamma variable 8 |
| chr2_+_201994208 | 1.32 |
ENST00000440180.1
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator |
| chr7_+_142000747 | 1.32 |
ENST00000455382.2
|
TRBV2
|
T cell receptor beta variable 2 |
| chr5_-_176937351 | 1.31 |
ENST00000377112.4
ENST00000501403.2 ENST00000312943.6 |
DOK3
|
docking protein 3 |
| chr2_+_201994042 | 1.30 |
ENST00000417748.1
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator |
| chr17_-_62097927 | 1.30 |
ENST00000578313.1
ENST00000584084.1 ENST00000579788.1 ENST00000579687.1 ENST00000578379.1 ENST00000578892.1 ENST00000412356.1 ENST00000418105.1 |
ICAM2
|
intercellular adhesion molecule 2 |
| chr19_-_1592828 | 1.28 |
ENST00000592012.1
|
MBD3
|
methyl-CpG binding domain protein 3 |
| chr20_+_814349 | 1.28 |
ENST00000381941.3
|
FAM110A
|
family with sequence similarity 110, member A |
| chr2_+_28853443 | 1.24 |
ENST00000436775.1
|
PLB1
|
phospholipase B1 |
| chr19_-_48894762 | 1.24 |
ENST00000600980.1
ENST00000330720.2 |
KDELR1
|
KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 1 |
| chr14_-_106066376 | 1.23 |
ENST00000412518.1
ENST00000428654.1 ENST00000427543.1 ENST00000420153.1 ENST00000577108.1 ENST00000576077.1 |
AL928742.12
IGHE
|
AL928742.12 immunoglobulin heavy constant epsilon |
| chr14_-_107283278 | 1.22 |
ENST00000390639.2
|
IGHV7-81
|
immunoglobulin heavy variable 7-81 (non-functional) |
| chr1_+_203274639 | 1.22 |
ENST00000290551.4
|
BTG2
|
BTG family, member 2 |
| chr2_-_32490859 | 1.21 |
ENST00000404025.2
|
NLRC4
|
NLR family, CARD domain containing 4 |
| chr22_-_36784035 | 1.20 |
ENST00000216181.5
|
MYH9
|
myosin, heavy chain 9, non-muscle |
| chr19_+_1407517 | 1.20 |
ENST00000336761.6
ENST00000233078.4 |
DAZAP1
|
DAZ associated protein 1 |
| chr15_-_60690163 | 1.20 |
ENST00000558998.1
ENST00000560165.1 ENST00000557986.1 ENST00000559780.1 ENST00000559467.1 ENST00000559956.1 ENST00000332680.4 ENST00000396024.3 ENST00000421017.2 ENST00000560466.1 ENST00000558132.1 ENST00000559113.1 ENST00000557906.1 ENST00000558558.1 ENST00000560468.1 ENST00000559370.1 ENST00000558169.1 ENST00000559725.1 ENST00000558985.1 ENST00000451270.2 |
ANXA2
|
annexin A2 |
| chr6_-_112575912 | 1.19 |
ENST00000522006.1
ENST00000230538.7 ENST00000519932.1 |
LAMA4
|
laminin, alpha 4 |
| chr3_-_133748913 | 1.18 |
ENST00000310926.4
|
SLCO2A1
|
solute carrier organic anion transporter family, member 2A1 |
| chr14_+_22409308 | 1.17 |
ENST00000390441.2
|
TRAV9-2
|
T cell receptor alpha variable 9-2 |
| chr19_-_36399149 | 1.17 |
ENST00000585901.2
ENST00000544690.2 ENST00000424586.3 ENST00000262629.4 ENST00000589517.1 |
TYROBP
|
TYRO protein tyrosine kinase binding protein |
| chr12_+_66582919 | 1.17 |
ENST00000545837.1
ENST00000457197.2 |
IRAK3
|
interleukin-1 receptor-associated kinase 3 |
| chr4_-_682769 | 1.16 |
ENST00000507165.1
|
MFSD7
|
major facilitator superfamily domain containing 7 |
| chr16_-_28518153 | 1.16 |
ENST00000356897.1
|
IL27
|
interleukin 27 |
| chr11_+_76494253 | 1.14 |
ENST00000333090.4
|
TSKU
|
tsukushi, small leucine rich proteoglycan |
| chr5_+_32710736 | 1.14 |
ENST00000415685.2
|
NPR3
|
natriuretic peptide receptor C/guanylate cyclase C (atrionatriuretic peptide receptor C) |
| chr11_+_1942580 | 1.14 |
ENST00000381558.1
|
TNNT3
|
troponin T type 3 (skeletal, fast) |
| chr22_+_24823517 | 1.13 |
ENST00000496258.1
ENST00000337539.7 |
ADORA2A
|
adenosine A2a receptor |
| chr11_-_59951430 | 1.13 |
ENST00000533409.1
|
MS4A6A
|
membrane-spanning 4-domains, subfamily A, member 6A |
| chr12_+_109569155 | 1.12 |
ENST00000539864.1
|
ACACB
|
acetyl-CoA carboxylase beta |
| chr20_+_816695 | 1.12 |
ENST00000246100.3
|
FAM110A
|
family with sequence similarity 110, member A |
| chr6_-_112575687 | 1.11 |
ENST00000521398.1
ENST00000424408.2 ENST00000243219.3 |
LAMA4
|
laminin, alpha 4 |
| chr6_+_31465849 | 1.11 |
ENST00000399150.3
|
MICB
|
MHC class I polypeptide-related sequence B |
| chr19_+_45349630 | 1.11 |
ENST00000252483.5
|
PVRL2
|
poliovirus receptor-related 2 (herpesvirus entry mediator B) |
| chr1_+_207925391 | 1.11 |
ENST00000358170.2
ENST00000354848.1 ENST00000322918.5 ENST00000367042.1 ENST00000367041.1 ENST00000357714.1 ENST00000322875.4 ENST00000367047.1 ENST00000441839.2 ENST00000361067.1 ENST00000360212.2 ENST00000480003.1 |
CD46
|
CD46 molecule, complement regulatory protein |
| chr8_-_9009079 | 1.11 |
ENST00000519699.1
|
PPP1R3B
|
protein phosphatase 1, regulatory subunit 3B |
| chr15_+_41056218 | 1.10 |
ENST00000260447.4
|
GCHFR
|
GTP cyclohydrolase I feedback regulator |
| chr11_+_844406 | 1.09 |
ENST00000397404.1
|
TSPAN4
|
tetraspanin 4 |
| chr5_+_176731572 | 1.08 |
ENST00000503853.1
|
PRELID1
|
PRELI domain containing 1 |
| chr12_-_125348329 | 1.08 |
ENST00000546215.1
ENST00000415380.2 ENST00000261693.6 ENST00000376788.1 ENST00000545493.1 |
SCARB1
|
scavenger receptor class B, member 1 |
| chr19_-_44031341 | 1.07 |
ENST00000600651.1
|
ETHE1
|
ethylmalonic encephalopathy 1 |
| chr8_-_11725549 | 1.07 |
ENST00000505496.2
ENST00000534636.1 ENST00000524500.1 ENST00000345125.3 ENST00000453527.2 ENST00000527215.2 ENST00000532392.1 ENST00000533455.1 ENST00000534510.1 ENST00000530640.2 ENST00000531089.1 ENST00000532656.2 ENST00000531502.1 ENST00000434271.1 ENST00000353047.6 |
CTSB
|
cathepsin B |
| chr11_-_60720002 | 1.07 |
ENST00000538739.1
|
SLC15A3
|
solute carrier family 15 (oligopeptide transporter), member 3 |
| chr22_+_50312274 | 1.06 |
ENST00000404488.3
|
CRELD2
|
cysteine-rich with EGF-like domains 2 |
| chr19_-_13213662 | 1.06 |
ENST00000264824.4
|
LYL1
|
lymphoblastic leukemia derived sequence 1 |
| chr20_+_37434329 | 1.04 |
ENST00000299824.1
ENST00000373331.2 |
PPP1R16B
|
protein phosphatase 1, regulatory subunit 16B |
| chr16_+_55522536 | 1.04 |
ENST00000570283.1
|
MMP2
|
matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) |
| chrX_+_9433289 | 1.03 |
ENST00000422314.1
|
TBL1X
|
transducin (beta)-like 1X-linked |
| chrX_-_48325857 | 1.03 |
ENST00000376875.1
|
SLC38A5
|
solute carrier family 38, member 5 |
| chrX_-_48326683 | 1.02 |
ENST00000440085.1
|
SLC38A5
|
solute carrier family 38, member 5 |
| chr5_+_38445641 | 1.00 |
ENST00000397210.3
ENST00000506135.1 ENST00000508131.1 |
EGFLAM
|
EGF-like, fibronectin type III and laminin G domains |
| chr6_+_31465892 | 0.98 |
ENST00000252229.6
ENST00000427115.1 |
MICB
|
MHC class I polypeptide-related sequence B |
| chr9_-_136242956 | 0.98 |
ENST00000371989.3
ENST00000485435.2 |
SURF4
|
surfeit 4 |
| chr2_+_219247021 | 0.98 |
ENST00000539932.1
|
SLC11A1
|
solute carrier family 11 (proton-coupled divalent metal ion transporter), member 1 |
| chr11_-_82612549 | 0.97 |
ENST00000528082.1
ENST00000533126.1 |
PRCP
|
prolylcarboxypeptidase (angiotensinase C) |
| chr6_-_24911195 | 0.96 |
ENST00000259698.4
|
FAM65B
|
family with sequence similarity 65, member B |
| chr12_-_39299406 | 0.96 |
ENST00000331366.5
|
CPNE8
|
copine VIII |
| chr19_+_56154913 | 0.95 |
ENST00000270451.5
ENST00000588537.1 |
ZNF581
|
zinc finger protein 581 |
| chr2_-_74780176 | 0.95 |
ENST00000409549.1
|
LOXL3
|
lysyl oxidase-like 3 |
| chr1_-_160832670 | 0.95 |
ENST00000368032.2
|
CD244
|
CD244 molecule, natural killer cell receptor 2B4 |
| chr12_-_80084594 | 0.95 |
ENST00000548426.1
|
PAWR
|
PRKC, apoptosis, WT1, regulator |
| chr1_+_201617450 | 0.95 |
ENST00000295624.6
ENST00000367297.4 ENST00000367300.3 |
NAV1
|
neuron navigator 1 |
| chr1_+_10459433 | 0.94 |
ENST00000465632.1
ENST00000460189.1 |
PGD
|
phosphogluconate dehydrogenase |
| chrX_-_153979315 | 0.94 |
ENST00000369575.3
ENST00000369568.4 ENST00000424127.2 |
GAB3
|
GRB2-associated binding protein 3 |
| chr1_-_154164534 | 0.94 |
ENST00000271850.7
ENST00000368530.2 |
TPM3
|
tropomyosin 3 |
| chr2_+_11295624 | 0.94 |
ENST00000402361.1
ENST00000428481.1 |
PQLC3
|
PQ loop repeat containing 3 |
| chr11_-_64901900 | 0.93 |
ENST00000526060.1
ENST00000307289.6 ENST00000528487.1 |
SYVN1
|
synovial apoptosis inhibitor 1, synoviolin |
| chr22_-_50689786 | 0.92 |
ENST00000216271.5
|
HDAC10
|
histone deacetylase 10 |
| chr11_-_64901978 | 0.92 |
ENST00000294256.8
ENST00000377190.3 |
SYVN1
|
synovial apoptosis inhibitor 1, synoviolin |
| chr3_+_69812877 | 0.92 |
ENST00000457080.1
ENST00000328528.6 |
MITF
|
microphthalmia-associated transcription factor |
| chr20_+_814377 | 0.91 |
ENST00000304189.2
ENST00000381939.1 |
FAM110A
|
family with sequence similarity 110, member A |
| chr1_+_16084428 | 0.90 |
ENST00000510929.1
ENST00000502638.1 |
FBLIM1
|
filamin binding LIM protein 1 |
| chr11_+_82612740 | 0.90 |
ENST00000524921.1
ENST00000528759.1 ENST00000525361.1 ENST00000430323.2 ENST00000533655.1 ENST00000532764.1 ENST00000532589.1 ENST00000525388.1 |
C11orf82
|
chromosome 11 open reading frame 82 |
| chr12_-_57504069 | 0.90 |
ENST00000543873.2
ENST00000554663.1 ENST00000557635.1 |
STAT6
|
signal transducer and activator of transcription 6, interleukin-4 induced |
| chr10_-_46089939 | 0.90 |
ENST00000453980.3
|
MARCH8
|
membrane-associated ring finger (C3HC4) 8, E3 ubiquitin protein ligase |
Network of associatons between targets according to the STRING database.
First level regulatory network of PPARG
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.7 | 5.2 | GO:0002416 | IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor(GO:0002416) |
| 1.2 | 5.0 | GO:1990736 | positive regulation of regulation of vascular smooth muscle cell membrane depolarization(GO:1904199) regulation of vascular smooth muscle cell membrane depolarization(GO:1990736) |
| 0.8 | 4.1 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
| 0.7 | 2.2 | GO:0002818 | intracellular defense response(GO:0002818) |
| 0.7 | 2.2 | GO:0002522 | leukocyte migration involved in immune response(GO:0002522) |
| 0.6 | 1.9 | GO:0043105 | regulation of GTP cyclohydrolase I activity(GO:0043095) negative regulation of GTP cyclohydrolase I activity(GO:0043105) |
| 0.6 | 1.8 | GO:0015920 | lipopolysaccharide transport(GO:0015920) |
| 0.6 | 2.8 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
| 0.6 | 3.3 | GO:0070945 | neutrophil mediated killing of gram-negative bacterium(GO:0070945) |
| 0.5 | 1.0 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
| 0.5 | 5.1 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
| 0.5 | 3.0 | GO:0038112 | interleukin-8-mediated signaling pathway(GO:0038112) |
| 0.5 | 1.5 | GO:0045554 | TRAIL biosynthetic process(GO:0045553) regulation of TRAIL biosynthetic process(GO:0045554) positive regulation of TRAIL biosynthetic process(GO:0045556) |
| 0.5 | 1.9 | GO:0002774 | Fc receptor mediated inhibitory signaling pathway(GO:0002774) |
| 0.5 | 3.2 | GO:0019556 | histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
| 0.4 | 5.1 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
| 0.4 | 6.2 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
| 0.4 | 4.1 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.4 | 2.4 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
| 0.4 | 2.0 | GO:0071400 | cellular response to oleic acid(GO:0071400) |
| 0.4 | 9.4 | GO:0048368 | lateral mesoderm development(GO:0048368) |
| 0.4 | 0.8 | GO:0048320 | axial mesoderm formation(GO:0048320) |
| 0.4 | 2.6 | GO:0002254 | regulation of thyroid hormone mediated signaling pathway(GO:0002155) kinin cascade(GO:0002254) plasma kallikrein-kinin cascade(GO:0002353) |
| 0.4 | 1.5 | GO:0098838 | reduced folate transmembrane transport(GO:0098838) |
| 0.4 | 2.2 | GO:0070295 | renal water absorption(GO:0070295) |
| 0.4 | 1.5 | GO:0099640 | axo-dendritic protein transport(GO:0099640) |
| 0.3 | 3.1 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 0.3 | 1.7 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
| 0.3 | 2.0 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
| 0.3 | 1.0 | GO:0055073 | cadmium ion homeostasis(GO:0055073) |
| 0.3 | 1.0 | GO:0071661 | granzyme B production(GO:0071613) regulation of granzyme B production(GO:0071661) positive regulation of granzyme B production(GO:0071663) |
| 0.3 | 1.9 | GO:0070221 | sulfide oxidation(GO:0019418) sulfide oxidation, using sulfide:quinone oxidoreductase(GO:0070221) |
| 0.3 | 1.9 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 0.3 | 25.0 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
| 0.3 | 1.8 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
| 0.3 | 0.6 | GO:0001300 | chronological cell aging(GO:0001300) |
| 0.3 | 1.2 | GO:0052418 | multi-organism catabolic process(GO:0044035) development of symbiont involved in interaction with host(GO:0044115) modulation of development of symbiont involved in interaction with host(GO:0044145) negative regulation of development of symbiont involved in interaction with host(GO:0044147) metabolism of substance in other organism involved in symbiotic interaction(GO:0052214) catabolism of substance in other organism involved in symbiotic interaction(GO:0052227) metabolism of macromolecule in other organism involved in symbiotic interaction(GO:0052229) catabolism by host of symbiont macromolecule(GO:0052360) catabolism by organism of macromolecule in other organism involved in symbiotic interaction(GO:0052361) catabolism by host of symbiont protein(GO:0052362) catabolism by organism of protein in other organism involved in symbiotic interaction(GO:0052363) catabolism by host of substance in symbiont(GO:0052364) metabolism by host of symbiont macromolecule(GO:0052416) metabolism by host of symbiont protein(GO:0052417) metabolism by organism of protein in other organism involved in symbiotic interaction(GO:0052418) metabolism by host of substance in symbiont(GO:0052419) |
| 0.3 | 4.1 | GO:0051712 | positive regulation of killing of cells of other organism(GO:0051712) |
| 0.3 | 1.4 | GO:0038156 | interleukin-5-mediated signaling pathway(GO:0038043) interleukin-3-mediated signaling pathway(GO:0038156) |
| 0.3 | 1.4 | GO:1903597 | negative regulation of gap junction assembly(GO:1903597) |
| 0.3 | 1.1 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
| 0.3 | 1.1 | GO:0070426 | positive regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070426) positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070434) |
| 0.3 | 1.4 | GO:0052027 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
| 0.3 | 2.1 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
| 0.3 | 0.8 | GO:0031204 | posttranslational protein targeting to membrane, translocation(GO:0031204) |
| 0.3 | 0.5 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
| 0.2 | 2.0 | GO:0034144 | negative regulation of toll-like receptor 4 signaling pathway(GO:0034144) |
| 0.2 | 1.4 | GO:0002018 | renin-angiotensin regulation of aldosterone production(GO:0002018) |
| 0.2 | 1.2 | GO:0032796 | uropod organization(GO:0032796) |
| 0.2 | 1.2 | GO:0018057 | peptidyl-lysine oxidation(GO:0018057) |
| 0.2 | 2.6 | GO:0070269 | pyroptosis(GO:0070269) |
| 0.2 | 1.8 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
| 0.2 | 0.9 | GO:0002296 | T-helper 1 cell lineage commitment(GO:0002296) |
| 0.2 | 3.5 | GO:0001955 | blood vessel maturation(GO:0001955) |
| 0.2 | 2.6 | GO:1903944 | regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
| 0.2 | 1.2 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
| 0.2 | 1.4 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
| 0.2 | 1.2 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
| 0.2 | 1.1 | GO:2001295 | malonyl-CoA biosynthetic process(GO:2001295) |
| 0.2 | 3.9 | GO:0060312 | regulation of blood vessel remodeling(GO:0060312) |
| 0.2 | 0.5 | GO:0002436 | immune complex clearance(GO:0002434) immune complex clearance by monocytes and macrophages(GO:0002436) astrocyte chemotaxis(GO:0035700) regulation of immune complex clearance by monocytes and macrophages(GO:0090264) positive regulation of immune complex clearance by monocytes and macrophages(GO:0090265) positive regulation of T cell extravasation(GO:2000409) positive regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000451) regulation of astrocyte chemotaxis(GO:2000458) |
| 0.2 | 1.1 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
| 0.2 | 0.8 | GO:0021650 | vestibulocochlear nerve formation(GO:0021650) |
| 0.2 | 8.3 | GO:0050855 | regulation of B cell receptor signaling pathway(GO:0050855) |
| 0.2 | 1.1 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
| 0.2 | 2.0 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
| 0.1 | 0.6 | GO:0006542 | glutamine biosynthetic process(GO:0006542) |
| 0.1 | 0.4 | GO:2000563 | CD4-positive, alpha-beta T cell proliferation(GO:0035739) regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000561) positive regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000563) |
| 0.1 | 0.8 | GO:0071603 | endothelial cell-cell adhesion(GO:0071603) |
| 0.1 | 3.6 | GO:0015671 | oxygen transport(GO:0015671) |
| 0.1 | 1.1 | GO:0045591 | positive regulation of regulatory T cell differentiation(GO:0045591) |
| 0.1 | 1.2 | GO:0046618 | drug export(GO:0046618) |
| 0.1 | 0.8 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
| 0.1 | 0.8 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 0.1 | 1.6 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
| 0.1 | 0.7 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
| 0.1 | 0.4 | GO:0097198 | histone H3-K36 trimethylation(GO:0097198) |
| 0.1 | 2.6 | GO:0015732 | prostaglandin transport(GO:0015732) |
| 0.1 | 0.7 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
| 0.1 | 0.6 | GO:0043335 | protein unfolding(GO:0043335) |
| 0.1 | 2.0 | GO:0015816 | glycine transport(GO:0015816) |
| 0.1 | 0.5 | GO:0006272 | leading strand elongation(GO:0006272) |
| 0.1 | 0.9 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 0.1 | 3.1 | GO:0002691 | regulation of cellular extravasation(GO:0002691) |
| 0.1 | 0.9 | GO:0007296 | vitellogenesis(GO:0007296) |
| 0.1 | 12.5 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
| 0.1 | 0.3 | GO:0021526 | medial motor column neuron differentiation(GO:0021526) |
| 0.1 | 0.5 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
| 0.1 | 1.3 | GO:0006477 | protein sulfation(GO:0006477) |
| 0.1 | 0.7 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
| 0.1 | 4.1 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
| 0.1 | 0.4 | GO:1905224 | clathrin-coated pit assembly(GO:1905224) |
| 0.1 | 1.2 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
| 0.1 | 0.7 | GO:1902019 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
| 0.1 | 1.4 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
| 0.1 | 3.4 | GO:0019835 | cytolysis(GO:0019835) |
| 0.1 | 0.3 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
| 0.1 | 0.6 | GO:0035897 | proteolysis in other organism(GO:0035897) |
| 0.1 | 1.4 | GO:0045048 | protein insertion into ER membrane(GO:0045048) |
| 0.1 | 1.2 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
| 0.1 | 3.4 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
| 0.1 | 1.1 | GO:0002158 | osteoclast proliferation(GO:0002158) |
| 0.1 | 0.4 | GO:0070124 | mitochondrial translational initiation(GO:0070124) |
| 0.1 | 0.6 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
| 0.1 | 0.8 | GO:0031017 | exocrine pancreas development(GO:0031017) |
| 0.1 | 0.9 | GO:0097398 | response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
| 0.1 | 0.7 | GO:1900086 | positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
| 0.1 | 0.2 | GO:0051389 | inactivation of MAPKK activity(GO:0051389) |
| 0.1 | 1.4 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
| 0.1 | 2.5 | GO:0045730 | respiratory burst(GO:0045730) |
| 0.1 | 1.1 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
| 0.1 | 0.4 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
| 0.1 | 0.3 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
| 0.1 | 1.9 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
| 0.1 | 0.9 | GO:2000680 | rubidium ion transport(GO:0035826) regulation of rubidium ion transport(GO:2000680) |
| 0.1 | 0.4 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
| 0.1 | 2.2 | GO:0044030 | regulation of DNA methylation(GO:0044030) |
| 0.1 | 1.2 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
| 0.1 | 12.8 | GO:0002377 | immunoglobulin production(GO:0002377) |
| 0.1 | 0.3 | GO:0051708 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
| 0.1 | 0.6 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
| 0.1 | 0.5 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
| 0.1 | 0.8 | GO:0007320 | insemination(GO:0007320) |
| 0.1 | 1.5 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
| 0.1 | 0.3 | GO:0050668 | cellular response to phosphate starvation(GO:0016036) positive regulation of sulfur amino acid metabolic process(GO:0031337) positive regulation of homocysteine metabolic process(GO:0050668) |
| 0.1 | 1.6 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
| 0.1 | 0.6 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
| 0.1 | 1.2 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
| 0.1 | 0.1 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
| 0.1 | 2.6 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
| 0.1 | 0.4 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) |
| 0.1 | 0.3 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
| 0.1 | 0.2 | GO:0072287 | metanephric distal tubule morphogenesis(GO:0072287) |
| 0.1 | 2.3 | GO:0001893 | maternal placenta development(GO:0001893) |
| 0.1 | 0.2 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
| 0.1 | 0.7 | GO:0021853 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
| 0.1 | 3.1 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
| 0.0 | 1.2 | GO:0060211 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
| 0.0 | 0.5 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
| 0.0 | 0.1 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
| 0.0 | 0.7 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
| 0.0 | 0.4 | GO:0010265 | SCF complex assembly(GO:0010265) |
| 0.0 | 0.4 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
| 0.0 | 0.7 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
| 0.0 | 4.6 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
| 0.0 | 1.4 | GO:0035455 | response to interferon-alpha(GO:0035455) |
| 0.0 | 0.5 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
| 0.0 | 1.0 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.0 | 2.1 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
| 0.0 | 0.8 | GO:0033623 | regulation of integrin activation(GO:0033623) |
| 0.0 | 0.3 | GO:1901620 | regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901620) |
| 0.0 | 0.6 | GO:0044351 | macropinocytosis(GO:0044351) |
| 0.0 | 2.4 | GO:0018149 | peptide cross-linking(GO:0018149) |
| 0.0 | 0.4 | GO:0045144 | meiotic sister chromatid segregation(GO:0045144) |
| 0.0 | 0.3 | GO:0086053 | AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
| 0.0 | 0.1 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
| 0.0 | 0.4 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
| 0.0 | 1.6 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
| 0.0 | 4.5 | GO:0002223 | stimulatory C-type lectin receptor signaling pathway(GO:0002223) |
| 0.0 | 2.1 | GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) |
| 0.0 | 2.0 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
| 0.0 | 0.5 | GO:0006682 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
| 0.0 | 2.1 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
| 0.0 | 0.3 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
| 0.0 | 0.5 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
| 0.0 | 1.3 | GO:2000144 | positive regulation of DNA-templated transcription, initiation(GO:2000144) |
| 0.0 | 3.1 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
| 0.0 | 0.3 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
| 0.0 | 1.5 | GO:0002042 | cell migration involved in sprouting angiogenesis(GO:0002042) |
| 0.0 | 0.7 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
| 0.0 | 1.6 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
| 0.0 | 0.5 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.0 | 0.9 | GO:0030225 | macrophage differentiation(GO:0030225) |
| 0.0 | 0.4 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
| 0.0 | 0.2 | GO:1902896 | terminal web assembly(GO:1902896) |
| 0.0 | 0.4 | GO:0043485 | endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
| 0.0 | 0.3 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.0 | 0.6 | GO:0071711 | basement membrane organization(GO:0071711) |
| 0.0 | 0.3 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
| 0.0 | 0.6 | GO:0032802 | low-density lipoprotein particle receptor catabolic process(GO:0032802) |
| 0.0 | 0.4 | GO:0006600 | creatine metabolic process(GO:0006600) |
| 0.0 | 0.5 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
| 0.0 | 4.0 | GO:0045995 | regulation of embryonic development(GO:0045995) |
| 0.0 | 2.2 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
| 0.0 | 0.2 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
| 0.0 | 2.8 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
| 0.0 | 0.6 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
| 0.0 | 0.1 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
| 0.0 | 0.3 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) positive regulation of neutrophil migration(GO:1902624) |
| 0.0 | 0.3 | GO:0051601 | exocyst localization(GO:0051601) |
| 0.0 | 0.5 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.0 | 0.1 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
| 0.0 | 0.4 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.0 | 0.3 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
| 0.0 | 0.7 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
| 0.0 | 0.8 | GO:0035987 | endodermal cell differentiation(GO:0035987) |
| 0.0 | 0.3 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
| 0.0 | 0.8 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
| 0.0 | 0.7 | GO:0031663 | lipopolysaccharide-mediated signaling pathway(GO:0031663) |
| 0.0 | 0.6 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
| 0.0 | 0.3 | GO:1990001 | inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
| 0.0 | 0.0 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
| 0.0 | 0.1 | GO:0042851 | L-alanine metabolic process(GO:0042851) L-alanine catabolic process(GO:0042853) |
| 0.0 | 1.5 | GO:0016575 | histone deacetylation(GO:0016575) |
| 0.0 | 0.5 | GO:0006298 | mismatch repair(GO:0006298) |
| 0.0 | 1.3 | GO:1900181 | negative regulation of protein localization to nucleus(GO:1900181) |
| 0.0 | 0.4 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.0 | 0.2 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
| 0.0 | 0.1 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
| 0.0 | 0.1 | GO:0006203 | dGTP catabolic process(GO:0006203) |
| 0.0 | 0.2 | GO:0017121 | phospholipid scrambling(GO:0017121) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.1 | 10.3 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
| 0.7 | 6.1 | GO:0044194 | cytolytic granule(GO:0044194) |
| 0.6 | 2.8 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
| 0.5 | 1.4 | GO:0030526 | granulocyte macrophage colony-stimulating factor receptor complex(GO:0030526) |
| 0.4 | 21.7 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
| 0.4 | 1.9 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
| 0.3 | 2.6 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
| 0.3 | 2.5 | GO:0032010 | phagolysosome(GO:0032010) |
| 0.3 | 2.0 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
| 0.3 | 2.6 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
| 0.2 | 1.2 | GO:1990667 | PCSK9-AnxA2 complex(GO:1990667) |
| 0.2 | 6.4 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
| 0.2 | 3.6 | GO:0005833 | hemoglobin complex(GO:0005833) |
| 0.2 | 1.1 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
| 0.2 | 0.8 | GO:0071665 | gamma-catenin-TCF7L2 complex(GO:0071665) |
| 0.2 | 0.6 | GO:0072563 | endothelial microparticle(GO:0072563) |
| 0.2 | 5.1 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
| 0.2 | 1.1 | GO:0036021 | endolysosome lumen(GO:0036021) |
| 0.1 | 5.0 | GO:0034706 | sodium channel complex(GO:0034706) |
| 0.1 | 0.4 | GO:0000818 | nuclear MIS12/MIND complex(GO:0000818) condensed chromosome inner kinetochore(GO:0000939) |
| 0.1 | 0.8 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
| 0.1 | 13.9 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
| 0.1 | 2.6 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) ripoptosome(GO:0097342) |
| 0.1 | 0.8 | GO:0098642 | network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) |
| 0.1 | 2.1 | GO:0030897 | HOPS complex(GO:0030897) |
| 0.1 | 4.6 | GO:0005605 | basal lamina(GO:0005605) |
| 0.1 | 0.3 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
| 0.1 | 0.5 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
| 0.1 | 0.9 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
| 0.1 | 0.7 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
| 0.1 | 3.3 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
| 0.1 | 1.8 | GO:0043194 | axon initial segment(GO:0043194) |
| 0.1 | 0.7 | GO:0036128 | CatSper complex(GO:0036128) |
| 0.1 | 0.7 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
| 0.1 | 0.5 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
| 0.1 | 0.4 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
| 0.1 | 0.3 | GO:0032449 | CBM complex(GO:0032449) |
| 0.1 | 0.8 | GO:0042587 | glycogen granule(GO:0042587) |
| 0.1 | 0.7 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
| 0.1 | 0.7 | GO:0046581 | intercellular canaliculus(GO:0046581) |
| 0.1 | 2.1 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
| 0.0 | 1.7 | GO:0042101 | T cell receptor complex(GO:0042101) |
| 0.0 | 1.1 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
| 0.0 | 11.5 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
| 0.0 | 0.2 | GO:0002133 | polycystin complex(GO:0002133) |
| 0.0 | 0.5 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
| 0.0 | 0.2 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
| 0.0 | 7.2 | GO:0072562 | blood microparticle(GO:0072562) |
| 0.0 | 2.4 | GO:0001533 | cornified envelope(GO:0001533) |
| 0.0 | 4.4 | GO:0035578 | azurophil granule lumen(GO:0035578) |
| 0.0 | 0.8 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
| 0.0 | 0.2 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
| 0.0 | 1.5 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
| 0.0 | 0.6 | GO:0030663 | COPI-coated vesicle membrane(GO:0030663) |
| 0.0 | 1.0 | GO:0005614 | interstitial matrix(GO:0005614) |
| 0.0 | 1.4 | GO:0019867 | mitochondrial outer membrane(GO:0005741) outer membrane(GO:0019867) organelle outer membrane(GO:0031968) |
| 0.0 | 0.8 | GO:0005845 | mRNA cap binding complex(GO:0005845) |
| 0.0 | 4.2 | GO:0043202 | lysosomal lumen(GO:0043202) |
| 0.0 | 2.0 | GO:1904115 | axon cytoplasm(GO:1904115) |
| 0.0 | 0.6 | GO:0036020 | endolysosome(GO:0036019) endolysosome membrane(GO:0036020) |
| 0.0 | 3.1 | GO:0000118 | histone deacetylase complex(GO:0000118) |
| 0.0 | 0.3 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
| 0.0 | 0.7 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
| 0.0 | 2.0 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
| 0.0 | 7.2 | GO:0009897 | external side of plasma membrane(GO:0009897) |
| 0.0 | 0.8 | GO:0031258 | lamellipodium membrane(GO:0031258) |
| 0.0 | 0.4 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
| 0.0 | 0.3 | GO:0000788 | nuclear nucleosome(GO:0000788) |
| 0.0 | 2.5 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
| 0.0 | 0.3 | GO:0001527 | microfibril(GO:0001527) fibril(GO:0043205) |
| 0.0 | 0.6 | GO:0030673 | axolemma(GO:0030673) |
| 0.0 | 0.3 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
| 0.0 | 1.9 | GO:0031672 | A band(GO:0031672) |
| 0.0 | 0.2 | GO:0033503 | HULC complex(GO:0033503) |
| 0.0 | 2.0 | GO:0005811 | lipid particle(GO:0005811) |
| 0.0 | 0.6 | GO:0035580 | specific granule lumen(GO:0035580) |
| 0.0 | 2.0 | GO:0005901 | caveola(GO:0005901) |
| 0.0 | 2.2 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
| 0.0 | 0.4 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
| 0.0 | 0.5 | GO:0071141 | SMAD protein complex(GO:0071141) |
| 0.0 | 1.2 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
| 0.0 | 0.2 | GO:0005902 | microvillus(GO:0005902) |
| 0.0 | 0.9 | GO:0032420 | stereocilium(GO:0032420) |
| 0.0 | 5.3 | GO:0030667 | secretory granule membrane(GO:0030667) |
| 0.0 | 0.6 | GO:0005796 | Golgi lumen(GO:0005796) |
| 0.0 | 0.2 | GO:0032433 | filopodium tip(GO:0032433) |
| 0.0 | 27.8 | GO:0005615 | extracellular space(GO:0005615) |
| 0.0 | 1.6 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
| 0.0 | 0.0 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
| 0.0 | 1.3 | GO:0005905 | clathrin-coated pit(GO:0005905) |
| 0.0 | 1.3 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
| 0.0 | 3.2 | GO:0001726 | ruffle(GO:0001726) |
| 0.0 | 0.1 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
| 0.0 | 0.3 | GO:0044853 | plasma membrane raft(GO:0044853) |
| 0.0 | 0.1 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
| 0.0 | 3.6 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
| 0.0 | 1.7 | GO:0030496 | midbody(GO:0030496) |
| 0.0 | 0.7 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
| 0.0 | 2.0 | GO:0001650 | fibrillar center(GO:0001650) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.7 | 5.1 | GO:0004119 | cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) |
| 1.1 | 3.4 | GO:0036328 | VEGF-C-activated receptor activity(GO:0036328) |
| 1.1 | 3.2 | GO:0004397 | histidine ammonia-lyase activity(GO:0004397) |
| 1.0 | 5.2 | GO:0019770 | IgG receptor activity(GO:0019770) |
| 1.0 | 3.1 | GO:0050135 | NAD(P)+ nucleosidase activity(GO:0050135) |
| 0.6 | 1.9 | GO:0044549 | GTP cyclohydrolase binding(GO:0044549) |
| 0.6 | 1.8 | GO:0070506 | high-density lipoprotein particle receptor activity(GO:0070506) |
| 0.5 | 3.0 | GO:0004918 | interleukin-8 receptor activity(GO:0004918) |
| 0.5 | 1.4 | GO:0001596 | angiotensin type I receptor activity(GO:0001596) |
| 0.4 | 2.2 | GO:0015254 | glycerol channel activity(GO:0015254) |
| 0.4 | 1.6 | GO:0008426 | protein kinase C inhibitor activity(GO:0008426) |
| 0.4 | 2.0 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
| 0.4 | 2.0 | GO:0032038 | myosin II heavy chain binding(GO:0032038) |
| 0.4 | 3.4 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
| 0.4 | 10.3 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
| 0.4 | 1.5 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
| 0.4 | 1.8 | GO:0031728 | CCR3 chemokine receptor binding(GO:0031728) |
| 0.3 | 3.1 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
| 0.3 | 21.7 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
| 0.3 | 1.7 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
| 0.3 | 1.0 | GO:0051139 | metal ion:proton antiporter activity(GO:0051139) |
| 0.3 | 4.8 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
| 0.3 | 1.2 | GO:0005046 | KDEL sequence binding(GO:0005046) |
| 0.3 | 1.4 | GO:0004912 | interleukin-3 receptor activity(GO:0004912) interleukin-5 receptor activity(GO:0004914) |
| 0.3 | 1.4 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
| 0.3 | 2.0 | GO:0004522 | ribonuclease A activity(GO:0004522) |
| 0.3 | 1.1 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
| 0.2 | 1.2 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
| 0.2 | 1.9 | GO:0032396 | inhibitory MHC class I receptor activity(GO:0032396) |
| 0.2 | 0.7 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
| 0.2 | 1.2 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
| 0.2 | 1.4 | GO:0022897 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
| 0.2 | 1.1 | GO:1990450 | linear polyubiquitin binding(GO:1990450) |
| 0.2 | 1.5 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
| 0.2 | 0.8 | GO:0005199 | structural constituent of cell wall(GO:0005199) |
| 0.2 | 1.2 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
| 0.2 | 0.6 | GO:0004766 | spermidine synthase activity(GO:0004766) |
| 0.2 | 2.1 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
| 0.2 | 1.3 | GO:0050119 | N-acetylglucosamine deacetylase activity(GO:0050119) |
| 0.2 | 1.1 | GO:0003989 | acetyl-CoA carboxylase activity(GO:0003989) |
| 0.2 | 4.1 | GO:0003680 | AT DNA binding(GO:0003680) |
| 0.2 | 1.1 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
| 0.2 | 8.1 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
| 0.2 | 0.7 | GO:0033981 | D-dopachrome decarboxylase activity(GO:0033981) |
| 0.2 | 3.6 | GO:0005344 | oxygen transporter activity(GO:0005344) |
| 0.2 | 2.4 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
| 0.2 | 2.1 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
| 0.2 | 1.6 | GO:0030882 | lipid antigen binding(GO:0030882) endogenous lipid antigen binding(GO:0030883) exogenous lipid antigen binding(GO:0030884) |
| 0.1 | 1.3 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
| 0.1 | 1.1 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
| 0.1 | 0.6 | GO:0016880 | glutamate-ammonia ligase activity(GO:0004356) ammonia ligase activity(GO:0016211) acid-ammonia (or amide) ligase activity(GO:0016880) |
| 0.1 | 2.5 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
| 0.1 | 2.0 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
| 0.1 | 0.8 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
| 0.1 | 1.2 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
| 0.1 | 4.2 | GO:0022829 | wide pore channel activity(GO:0022829) |
| 0.1 | 1.4 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
| 0.1 | 2.6 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
| 0.1 | 2.6 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
| 0.1 | 1.2 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
| 0.1 | 21.8 | GO:0003823 | antigen binding(GO:0003823) |
| 0.1 | 1.1 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
| 0.1 | 0.5 | GO:0035500 | MH2 domain binding(GO:0035500) |
| 0.1 | 0.5 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
| 0.1 | 0.9 | GO:0043426 | MRF binding(GO:0043426) |
| 0.1 | 11.4 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
| 0.1 | 0.3 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
| 0.1 | 0.9 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
| 0.1 | 5.7 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
| 0.1 | 0.9 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
| 0.1 | 2.6 | GO:0042288 | MHC class I protein binding(GO:0042288) |
| 0.1 | 2.5 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
| 0.1 | 0.6 | GO:0016936 | galactoside binding(GO:0016936) |
| 0.1 | 1.9 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
| 0.1 | 4.7 | GO:0005158 | insulin receptor binding(GO:0005158) |
| 0.1 | 0.6 | GO:0005534 | galactose binding(GO:0005534) |
| 0.1 | 0.6 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
| 0.1 | 3.1 | GO:0005123 | death receptor binding(GO:0005123) |
| 0.1 | 0.4 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
| 0.1 | 0.3 | GO:0043398 | HLH domain binding(GO:0043398) |
| 0.1 | 0.5 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
| 0.1 | 2.0 | GO:0005003 | ephrin receptor activity(GO:0005003) |
| 0.1 | 0.3 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
| 0.1 | 0.8 | GO:1901612 | cardiolipin binding(GO:1901612) |
| 0.1 | 0.5 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
| 0.1 | 1.2 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
| 0.1 | 0.7 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
| 0.1 | 3.1 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
| 0.1 | 0.5 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
| 0.0 | 1.2 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
| 0.0 | 1.2 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
| 0.0 | 0.1 | GO:0033867 | Fas-activated serine/threonine kinase activity(GO:0033867) |
| 0.0 | 0.2 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
| 0.0 | 0.5 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
| 0.0 | 0.8 | GO:0042834 | peptidoglycan binding(GO:0042834) |
| 0.0 | 1.6 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
| 0.0 | 0.5 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
| 0.0 | 0.5 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
| 0.0 | 0.4 | GO:0004111 | creatine kinase activity(GO:0004111) |
| 0.0 | 0.4 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
| 0.0 | 0.7 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
| 0.0 | 4.3 | GO:0001618 | virus receptor activity(GO:0001618) |
| 0.0 | 0.4 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
| 0.0 | 0.6 | GO:0016803 | ether hydrolase activity(GO:0016803) |
| 0.0 | 1.0 | GO:0008527 | taste receptor activity(GO:0008527) |
| 0.0 | 0.5 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
| 0.0 | 3.0 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
| 0.0 | 0.3 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) |
| 0.0 | 0.8 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
| 0.0 | 2.1 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
| 0.0 | 4.9 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
| 0.0 | 2.5 | GO:0005044 | scavenger receptor activity(GO:0005044) |
| 0.0 | 0.5 | GO:0022850 | serotonin-gated cation channel activity(GO:0022850) |
| 0.0 | 0.3 | GO:0016206 | catechol O-methyltransferase activity(GO:0016206) |
| 0.0 | 1.7 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
| 0.0 | 1.0 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
| 0.0 | 2.7 | GO:0016667 | oxidoreductase activity, acting on a sulfur group of donors(GO:0016667) |
| 0.0 | 1.9 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
| 0.0 | 0.4 | GO:0031996 | thioesterase binding(GO:0031996) |
| 0.0 | 3.7 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
| 0.0 | 0.8 | GO:0031005 | filamin binding(GO:0031005) |
| 0.0 | 0.6 | GO:0017160 | Ral GTPase binding(GO:0017160) |
| 0.0 | 0.4 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
| 0.0 | 0.6 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
| 0.0 | 0.8 | GO:0000339 | RNA cap binding(GO:0000339) |
| 0.0 | 0.7 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
| 0.0 | 0.3 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
| 0.0 | 0.1 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
| 0.0 | 0.1 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
| 0.0 | 0.3 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
| 0.0 | 0.6 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
| 0.0 | 0.7 | GO:0051059 | NF-kappaB binding(GO:0051059) |
| 0.0 | 0.5 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
| 0.0 | 0.1 | GO:0035529 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) NADH pyrophosphatase activity(GO:0035529) 8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity(GO:0035539) |
| 0.0 | 9.4 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
| 0.0 | 5.2 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
| 0.0 | 4.5 | GO:0005539 | glycosaminoglycan binding(GO:0005539) |
| 0.0 | 3.3 | GO:0005178 | integrin binding(GO:0005178) |
| 0.0 | 0.7 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
| 0.0 | 0.6 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
| 0.0 | 0.2 | GO:0042609 | CD4 receptor binding(GO:0042609) |
| 0.0 | 0.2 | GO:0060229 | phospholipase activator activity(GO:0016004) lipase activator activity(GO:0060229) |
| 0.0 | 0.5 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
| 0.0 | 0.3 | GO:0019841 | retinol binding(GO:0019841) |
| 0.0 | 0.4 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
| 0.0 | 3.2 | GO:0005125 | cytokine activity(GO:0005125) |
| 0.0 | 0.4 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
| 0.0 | 1.6 | GO:0008013 | beta-catenin binding(GO:0008013) |
| 0.0 | 0.3 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
| 0.0 | 1.2 | GO:0019903 | protein phosphatase binding(GO:0019903) |
| 0.0 | 0.5 | GO:0042169 | SH2 domain binding(GO:0042169) |
| 0.0 | 1.7 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
| 0.0 | 0.2 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
Gene overrepresentation in curated gene sets: canonical pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.2 | 3.4 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
| 0.1 | 10.0 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
| 0.1 | 5.4 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
| 0.1 | 6.0 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
| 0.1 | 3.9 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
| 0.1 | 1.4 | PID IL5 PATHWAY | IL5-mediated signaling events |
| 0.1 | 2.8 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
| 0.1 | 1.5 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
| 0.1 | 5.5 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
| 0.1 | 2.6 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
| 0.1 | 2.9 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
| 0.1 | 3.0 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
| 0.1 | 1.6 | PID IL23 PATHWAY | IL23-mediated signaling events |
| 0.0 | 4.5 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
| 0.0 | 0.8 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
| 0.0 | 0.8 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
| 0.0 | 2.5 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
| 0.0 | 1.5 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
| 0.0 | 2.3 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
| 0.0 | 1.3 | PID ARF 3PATHWAY | Arf1 pathway |
| 0.0 | 1.8 | PID NECTIN PATHWAY | Nectin adhesion pathway |
| 0.0 | 1.8 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
| 0.0 | 1.9 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
| 0.0 | 1.9 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
| 0.0 | 1.2 | PID IL27 PATHWAY | IL27-mediated signaling events |
| 0.0 | 4.2 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
| 0.0 | 2.9 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
| 0.0 | 0.7 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
| 0.0 | 0.6 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
| 0.0 | 0.8 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
| 0.0 | 1.1 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
| 0.0 | 0.3 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
| 0.0 | 1.2 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
| 0.0 | 7.0 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
| 0.0 | 0.9 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
| 0.0 | 0.6 | PID ALK1 PATHWAY | ALK1 signaling events |
| 0.0 | 4.6 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
| 0.0 | 0.4 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
| 0.0 | 0.9 | PID RAC1 PATHWAY | RAC1 signaling pathway |
| 0.0 | 0.6 | PID IL1 PATHWAY | IL1-mediated signaling events |
| 0.0 | 0.5 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
| 0.0 | 1.6 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
| 0.0 | 2.6 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
Gene overrepresentation in curated gene sets: REACTOME pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.2 | 12.2 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
| 0.2 | 2.3 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
| 0.2 | 4.0 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
| 0.1 | 3.4 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
| 0.1 | 10.9 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
| 0.1 | 2.2 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
| 0.1 | 15.8 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
| 0.1 | 1.5 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
| 0.1 | 1.9 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
| 0.1 | 5.1 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
| 0.1 | 2.6 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
| 0.1 | 3.5 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
| 0.1 | 2.6 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
| 0.1 | 1.1 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
| 0.1 | 1.1 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
| 0.1 | 1.8 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
| 0.1 | 3.5 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
| 0.1 | 5.4 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
| 0.1 | 2.6 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
| 0.1 | 1.8 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
| 0.1 | 1.4 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
| 0.0 | 4.0 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
| 0.0 | 4.8 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
| 0.0 | 4.1 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
| 0.0 | 1.5 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
| 0.0 | 1.2 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
| 0.0 | 1.9 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
| 0.0 | 0.4 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
| 0.0 | 0.8 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
| 0.0 | 2.7 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
| 0.0 | 1.0 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
| 0.0 | 0.8 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
| 0.0 | 1.1 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
| 0.0 | 0.5 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
| 0.0 | 2.1 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
| 0.0 | 0.8 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
| 0.0 | 1.3 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
| 0.0 | 1.1 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
| 0.0 | 0.6 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
| 0.0 | 0.9 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
| 0.0 | 0.7 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
| 0.0 | 1.2 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
| 0.0 | 0.6 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
| 0.0 | 0.8 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
| 0.0 | 2.2 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
| 0.0 | 0.8 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
| 0.0 | 0.3 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
| 0.0 | 0.6 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
| 0.0 | 1.6 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
| 0.0 | 1.3 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
| 0.0 | 0.9 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
| 0.0 | 1.5 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
| 0.0 | 1.2 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
| 0.0 | 0.5 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
| 0.0 | 0.8 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
| 0.0 | 1.2 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
| 0.0 | 3.1 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
| 0.0 | 0.6 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |